Now, many people are understandably flummoxed by a very active campaign to convince the public that CBD is different depending on whether it’s derived from marijuana or hemp. Hemp and marijuana are both Cannabis. Hemp is Cannabis sativa, and marijuana is either Cannabis sativa or Cannabis indica. Hemp is simply the common and legal term for cannabis that contains less than .3% THC, and marijuana is the common and legal term for cannabis that contains .3% and more THC.
Flower Power, which sells CBD-infused coffee to cafes like Caffeine Underground in New York City, puts 5 mg of CBD in each serving of coffee. The company, like many involved in the sale of CBD, is extremely careful about what it says regarding CBD’s effects for fear of FDA intervention. The standard language for CBD packaging and website documentation is similar to that of many supplements (think: milk thistle, echinacea, elderberry, turmeric) and is some variation on: “These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease or ailment.”
Cannabigerol is known as the stem cell cannabinoid for its role as a precursor to other cannabinoids found in hemp. Previously overlooked as a significant cannabinoid, the role of CBG is becoming better understood, and companies are starting to research its potential. Because most CBG is transformed into other cannabinoids like CBD or THC by the cannabis plant, natural CBG levels are low in most processed cannabis plants.
In the United States, non-FDA approved CBD products are classified as Schedule I drugs under the Controlled Substances Act. This means that production, distribution, and possession of non-FDA approved CBD products is illegal under federal law. In addition, in 2016 the Drug Enforcement Administration added "marijuana extracts" to the list of Schedule I drugs, which it defined as "an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant." Previously, CBD had simply been considered "marijuana", which is a Schedule I drug.
The only study that has tested the bioavailability of inhaled CBD is from 2014; it found a bioavailability of about 25 percent for 100 mg and 200 mg doses of CBD using a Volcano vaporizer. (The topical lotions are even less studied; there have been no clinical trials on them at all.) This is more efficient than ingesting CBD, in the same way that vaporizing THC is more efficient than eating it. To get an effect, you should ingest a different amount of CBD than you’d inhale ... but how much is that? How much is too much?
CBD Isolates/Concentrates: Anyone familiar with smoking hash or other cannabis concentrates like wax and BHO will be no stranger to this delivery method. Simply sprinkle some into a vaporizer or water pipe, ignite, inhale, and enjoy! We find that this option is useful for individuals looking to elevate their regular consumption of CBD-rich cannabis flowers or other smokable herbs.
The final advantage in the above list of a lower cost per milligram is one worth looking into further. As previously mentioned, because a full spectrum product is derived from a whole plant ex-tract it typically costs more (you the consumer are getting more than just CBD). Chase Terwilliger, CEO of CBDistillery, adds, "It is less expensive to manufacture isolate-based products com-pared to full-spectrum products. Rather than taking advantage of a larger margin, we decided to pass the savings along to the consumers." For those looking for a pure CBD product, you will al-so be delighted to find that CBD oil made from isolate is typically less expensive than a full-spectrum product. Which brings up a final point which is to do your research on the industry standard pricing for cost per milligram to ensure you are not paying an unnecessary premium.